Skip to main content

Table 2 Logistic regression modal of the association between fatigue and clinical characteristics in PD patients

From: Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment

Variable Univariate analysis   Multivariate analysis  
odds ratio P -value odds ratio P -value
Female sex (n= 222) 1.594 (0.926–2.742) 0.092   
Age, y (n= 222) 1.009 (0.982–1.037) 0.522   
Onset age, y (n= 222) 1.000 (0.974–1.027) 0.992   
Duration of disease, y (n= 222) 1.100 (1.000–1.208) 0.049*   
Education, y (n= 222) 0.935 (0.864–1.011) 0.091   
LEDD (mg/day) (n= 222) 1.001 (1.000–1.002) 0.083   
H-Y stage (n= 222) 1.578 (1.102–2.258) 0.013*   
UPDRS total score (n= 222) 1.033 (1.018–1.048) <0.001*   
UPDRS part I (n= 222) 1.333 (1.159–1.533) <0.001*   
UPDRS part II (n= 222) 1.122 (1.059–1.189) <0.001*   
UPDRS part III (n= 222) 1.036 (1.016–1.056) <0.001*   
UPDRS part IV (n= 222) 1.210 (1.049–1.396) 0.009*   
HAMD score (n= 177) 1.079 (1.016–1.146) 0.013*   
PDSS (n= 177) 0.967 (0.954–0.981) <0.001* 0.974 (0.959–0.989) 0.001
MoCA score (n= 222) 0.948 (0.890–1.009) 0.094   
  1. Figures in parentheses indicate 95 % confidence intervals. *Significant difference. H-Y stage Hoehn & Yahr staging, LEDD levodopa equivalent daily dosage, UPDRS Unified Parkinson’ Disease Rating Scale, MoCA Montreal Cognitive Assessment, HAMD Hamilton Depression Scale score, PDSS Parkinson’s Disease Sleep Scale